Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma

NCT00479765 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.

NCT NCT00479765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00479765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGel™ in Subjects With Recurrent Glioma
Lead sponsor
Boston Scientific Corporation
Phase
Phase 1/2
Overall status
Terminated
Start date
March 31, 2007
Completion date
October 31, 2009
Enrollment
4 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

brain neoplasms, glioblastoma multiforme